Related Experiment Videos
[Recurrent post-infectious immune complex glomerulonephritis with persistent activation of the alternative complement
M Arslan-Kirchner1, J H Ehrich, M Kirschfink
1Kinderklinik, Medizinischen Hochschule Hannover.
Summary
A 4-year-old boy with recurrent respiratory infections developed acute nephritic syndrome. Treatment with immunosuppressants and methyl-prednisolone improved renal function, but persistent complement activation was noted.
Area of Science:
- Pediatric Nephrology
- Immunology
- Glomerular Diseases
Background:
- Recurrent upper respiratory tract infections can precede serious renal complications in children.
- Acute nephritic syndrome presents a significant challenge in pediatric cases, often requiring intensive management.
- Immune complex glomerulonephritis is a key differential diagnosis in children with nephritic syndrome.
Observation:
- A previously healthy 4-year-old boy presented with acute nephritic syndrome after recurrent upper respiratory infections, necessitating hemodialysis.
- Renal biopsy revealed post-streptococcal-like immune complex glomerulonephritis characterized by subepithelial humps, C3 deposition, and crescent formation.
- Despite initial improvement with methyl-prednisolone pulse therapy, the patient experienced two relapses within six months, requiring further immunosuppressive treatment.
Findings:
- The patient achieved normal glomerular filtration rate 21 months post-presentation but exhibited persistent glomerular proteinuria and hematuria.
- Detailed complement analyses demonstrated ongoing activation of the alternate complement pathway.
- The findings suggest a link between persistent alternate pathway activation and the long-term renal sequelae.
Implications:
- This case highlights the importance of monitoring complement activation in pediatric glomerulonephritis, particularly post-infectious types.
- Understanding persistent alternate pathway activation may lead to targeted therapeutic strategies for refractory or relapsing cases.
- Further research into the role of complement in pediatric kidney disease is warranted to improve patient outcomes.